National Institute of Neurological Disorders and Stroke; Notice of Meeting, 20691-20692 [2011-8935]
Download as PDF
<![CDATA[
mstockstill on DSKH9S0YB1PROD with NOTICES
Federal Register / Vol. 76, No. 71 / Wednesday, April 13, 2011 / Notices
purpose of the public workshop is to
facilitate discussion among FDA and
worldwide orthopedic registries that
have orthopedic implant information
and create a research network to
advance the methodology and conduct
of research related to orthopedic device
performance.
Date and Time: The public workshop
will be held on May 9, 2011, from 8 a.m.
to 5:30 p.m.
Location: The public workshop will
be held at the FDA White Oak Campus,
10903 New Hampshire Ave., Bldg. 31,
rm. 1503 (the Great Room), Silver
Spring, MD 20993. Participants are
encouraged to arrive early to ensure
time for parking and security screening
before the meeting.
Contacts:
For information regarding the public
workshop and registration: Betty Jo
Alfstad, Surgical Outcomes and
Analysis, Kaiser Permanente, 3033
Bunker Hill Street, B30, San Diego, CA
92109, 858–581–8272, e-mail:
Betty.Jo.Alfstad@kp.org;
For information regarding this notice:
Tamia Woodruff, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Silver Spring, MD 20993, 307–
796–6091, e-mail:
Tamia.Woodruff@fda.hhs.gov.
Registration: There is no fee to attend
the public workshop, but attendees
must register in advance. Registration
will be on a first-come, first-served
basis. Non-U.S. citizens are subject to
additional security screening, and they
should register as soon as possible.
Registration ends April 25, 2011. Onsite
registration is not available. If
registration reaches maximum capacity
prior to April 25, 2011, FDA will post
a notice closing workshop registration
on FDA’s Web site at https://
www.fda.gov/cdrh/meetings.html.
To register for the public workshop,
mail or e-mail your name, title,
organization affiliation, address, phone
number, and email address to Betty Jo
Alfstad (see Contacts). Registrants will
receive e-mail confirmation upon
acceptance for their participation in the
public workshop. If you need special
accommodations due to a disability,
please contact Tamia Woodruff (see
Contacts) at least 7 days in advance of
the public workshop.
SUPPLEMENTARY INFORMATION:
I. Why are we holding this public
workshop?
The purpose of the public workshop
is to facilitate discussion among FDA
and international orthopedic registries
and develop a research consortium
(ICOR) that will advance the
VerDate Mar<15>2010
18:37 Apr 12, 2011
Jkt 223001
methodology and conduct of studies for
orthopedic medical devices. We are
reaching out to registries that have
relevant data and are interested in
collaboration to establish a network that
will work with FDA to determine the
evidence gaps and questions, datasets
and approaches for conducting robust
analytic studies and improve our
understanding of the performance of
orthopedic devices.
II. Who is the target audience for this
public workshop? Who should attend
this public workshop?
This workshop is open to all
interested parties. The target audience is
comprised of data holders, researchers,
and industry interested in advancing the
infrastructure and methods for studying
orthopedic medical devices.
III. What are the topics we intend to
address at the public workshop?
We intend to discuss a large number
of issues at the workshop, including, but
not limited to the following:
• Regulatory science, clinical
community, payers’ and patients’ needs
that led to creation of ICOR.
• New methods for distributed
network based collaborative studies.
• The opportunities for medical
device outcomes research.
IV. Where can I find out more about
this public workshop?
Background information on the public
workshop, registration information, the
agenda, information about lodging, and
other relevant information will be
posted, as it becomes available, on the
Internet at https://www.fda.gov/cdrh/
meetings.html.
Dated: April 7, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–8894 Filed 4–12–11; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
20691
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group; Neurological Sciences and
Disorders C.
Date: June 9–10, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Lorien Hotel and Spa, 1600 King
Street, Washington, DC 22314.
Contact Person: William C. Benzing, PhD,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS/Neuroscience Center,
6001 Executive Blvd., Suite 3208, MSC 9529,
Bethesda, MD 20892, 301–496–0660,
benzingw@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: April 6, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–8965 Filed 4–12–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the National Advisory
Neurological Disorders and Stroke
Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
E:\FR\FM\13APN1.SGM
13APN1
20692
Federal Register / Vol. 76, No. 71 / Wednesday, April 13, 2011 / Notices
mstockstill on DSKH9S0YB1PROD with NOTICES
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: May 26–27, 2011.
Open: May 26, 2011, 10:45 a.m. to 4:45
p.m.
Agenda: Report by the Director, NINDS;
Report by the Associate Director for
Extramural Research, NINDS; Other
Administrative and Program Developments;
and an Overview of the NINDS Intramural
Program.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 10, Bethesda, MD 20892.
Closed: May 26, 2011, 4:45 p.m. to 5:15
p.m.
Agenda: To review and evaluate the
Division of Intramural Research Board of
Scientific Counselors Reports.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 10, Bethesda, MD 20892.
Closed: May 27, 2011, 8 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 10, Bethesda, MD 20892.
Contact Person: Robert Finkelstein, PhD,
Associate Director for Extramural Research,
National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892, (301)
496–9248.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https:///
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: April 7, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–8935 Filed 4–12–11; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
18:37 Apr 12, 2011
Jkt 223001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cardiac Electrophysiology.
Date: May 19, 2011.
Time: 2:30 p.m. to 5 p.m.
Agenda:To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Maqsood A. Wani, DVM,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2114,
MSC 7814, Bethesda, MD 20892, 301–435–
2270, wanimaqs@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PA–11–
011—Getting from Genes to Function in Lung
Disease.
Date: May 25–26, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ghenima Dirami, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4122,
MSC 7814, Bethesda, MD 20892, 301–594–
1321, diramig@csr.nih.gov.
Name of Committee: Oncology 1-Basic
Translational Integrated Review Group;
Tumor Progression and Metastasis Study
Section.
Date: May 26–27, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: Rolf Jakobi, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 6187, MSC 7806, Bethesda, MD
20892, 301–495–1718, jakobir@mail.nih.gov.
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Investigations on Primary Immunodeficiency
Diseases.
Date: May 26, 2011.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Scott Jakes, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4198, MSC 7812, Bethesda, MD
20892, 301–495–1506, jakesse@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 7, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–8933 Filed 4–12–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Diabetes,
Endocrinology and Metabolic Diseases B
Subcommittee.
Date: May 31–June 2, 2011.
E:\FR\FM\13APN1.SGM
13APN1
]]>Agencies
[Federal Register Volume 76, Number 71 (Wednesday, April 13, 2011)]
[Notices]
[Pages 20691-20692]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-8935]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the National
Advisory Neurological Disorders and Stroke Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable materials,
[[Page 20692]]
and personal information concerning individuals associated with the
grant applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Advisory Neurological Disorders and
Stroke Council.
Date: May 26-27, 2011.
Open: May 26, 2011, 10:45 a.m. to 4:45 p.m.
Agenda: Report by the Director, NINDS; Report by the Associate
Director for Extramural Research, NINDS; Other Administrative and
Program Developments; and an Overview of the NINDS Intramural
Program.
Place: National Institutes of Health, Building 31, 31 Center
Drive, C Wing, Conference Room 10, Bethesda, MD 20892.
Closed: May 26, 2011, 4:45 p.m. to 5:15 p.m.
Agenda: To review and evaluate the Division of Intramural
Research Board of Scientific Counselors Reports.
Place: National Institutes of Health, Building 31, 31 Center
Drive, C Wing, Conference Room 10, Bethesda, MD 20892.
Closed: May 27, 2011, 8 a.m. to 11 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, C Wing, Conference Room 10, Bethesda, MD 20892.
Contact Person: Robert Finkelstein, PhD, Associate Director for
Extramural Research, National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite 3309, MSC 9531,
Bethesda, MD 20892, (301) 496-9248.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https:///www.ninds.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS).
Dated: April 7, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-8935 Filed 4-12-11; 8:45 am]
BILLING CODE 4140-01-P
